Discover MabDesign
MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.
Access our network
Join the MabDesign network to take advantage of all the advantages and opportunities offered.
Develop your skills
Consult and register for our next training courses in order to acquire new expertise.
Explore our business services
The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.
Our News
ZOOM ON - MImabs
MImAbs is a French CRO with 12 years of innovation in antibody science and a strong partnership-driven mindset. As part of Janvier Group Biosciences, we leverage cutting-edge technologies and deep expertise to support drug-development programs from early antibody discovery to advanced engineering and comprehensive characterization.
ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025
ImCheck Therapeutics today announced updated results from its Phase I/II EVICTION study evaluating ICT01, a first-in-class γ9δ2 T-cell activator, in combination with azacitidine and venetoclax in newly diagnosed AML patients ineligible for intensive chemotherapy.
OUR BOARD OF DIRECTORS
